Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54)

The summary for the Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54): This Funding Opportunity Announcement (FOA) encourages applications to establish Collaborative Centers to study ethical, legal and societal issues (ELSI) of human genome and environmental health research across the African continent. Of particular interest are projects that propose bioethical, legal, and social science analyses of new or emerging issues that affect multiple communities across the continent of Africa. These awards will support 3-5 collaborating research projects at three or more African institutions working together as a partnership to accomplish more than each project could accomplish on its own.
Federal Grant Title: Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-17-020
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Information not provided
Current Application Deadline: December 6th, 2017
Original Application Deadline: December 6th, 2017
Posted Date: September 19th, 2017
Creation Date: September 19th, 2017
Archive Date: January 11th, 2018
Total Program Funding:
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: September 19th, 2017
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the funding opportunity for eligibility details
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-17-020.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com